What's breaking now, across thousands of outlets.
There's a very strong case for weathering a bear market storm so you can benefit from the coming bull market.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Eli Lilly is dominating the GLP-1 market with nearly 50% revenue growth and a newly approved oral obesity pill. Pfizer is rebuilding its pipeline with obesity drug ambitions and a committed dividend…
Key PointsThere’s still plenty of innovation to find within the weight-loss drug space.
Softdocs' cloud-based content management and workflow automation software is used by more than 1,000 organizations worldwide.
AST SpaceMobile stock is down nearly 60% from its 52-week high of nearly $134.
Strategy bought 334 Bitcoin for $28.7 million last week while spending $176.3 million to repurchase about 1.77 million shares of STRC.
Consumption of crude is still rising
